The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin
Sponsor
Hadassah Medical Organization (Other)
Overall Status
Unknown status
CT.gov ID
NCT00354796
Collaborator
(none)
500
1
111
4.5
Study Details
Study Description
Brief Summary
We hypothesize that reduced dose of enoxaparin in elderly patients will result in reduced proportion of patients with therapeutic anti Xa activity and reduced clinical efficacy.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Detailed Description
Patients treated with enoxaparin will be followed, sociodemographic , clinical and laboratory data will be collected. Clinical efficacy as well as adverse events will be monitored.
Study Design
Study Type:
Observational
Anticipated Enrollment
:
500 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Effect of Reduced Dose of Enoxaparin on the Laboratory and Clinical Outcomes of Treatment With Enoxaparin
Study Start Date
:
Jul 1, 2006
Anticipated Study Completion Date
:
Oct 1, 2015
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- treatment with enoxaparin
Exclusion Criteria:
- no
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Hadassah Medical Organization | Jerusalem | Israel | 91120 |
Sponsors and Collaborators
- Hadassah Medical Organization
Investigators
- Principal Investigator: Mordechai Muszkat, MD, Hadassah University Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00354796
Other Study ID Numbers:
- enoxap-HMO-CTIL
First Posted:
Jul 20, 2006
Last Update Posted:
Jul 6, 2011
Last Verified:
Jun 1, 2011
Keywords provided by ,
,
Additional relevant MeSH terms: